YURLO

Serial Number 99228564
688

Registration Progress

Application Filed
Jun 11, 2025
Under Examination
Dec 16, 2025
Approved for Publication
Oct 21, 2025
Published for Opposition
Oct 21, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jun 16, 2026 156 days

Trademark Image

YURLO

Basic Information

Serial Number
99228564
Filing Date
June 11, 2025
Published for Opposition
October 21, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Dec 16, 2025
Application
Pending
Classes
005

Rights Holder

AstraZeneca AB

64
Address
SE-151 85 Södertälje
Södertälje SE-15185
SE

Ownership History

AstraZeneca AB

Original Applicant
64
Södertälje SE

AstraZeneca AB

Owner at Publication
64
Södertälje SE

Legal Representation

Attorney
Cara M. Kearney

USPTO Deadlines

Next Deadline
156 days remaining
NOA E-Mailed - SOU Required
Due Date
June 16, 2026
Extension Available
Until December 16, 2026

Application History

9 events
Date Code Type Description Documents
Dec 16, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 21, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 21, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 15, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 21, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 21, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 11, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jun 11, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 11, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Antibodies for medical purposes; Vaccines

Classification

International Classes
005